Ch. 1Company Bankruptcy, Late-Stage Liver Cancer

Key Plot Points and Events

  • Wei Kang's company is on the brink of bankruptcy due to failed drug research and financial losses.
  • The company's vice president, Sun Chengren, presents a grim report and suggests selling the company to Xinmei Group.
  • Wei Kang discovers he has late-stage liver cancer with less than a year to live.
  • He activates a pharmaceutical system that offers him points based on the use of his new drugs.

Character Developments

  • Wei Kang, the protagonist, inherits his family's pharmaceutical company after his parents' death and struggles to keep it afloat. He is determined, responsible, and initially overwhelmed by his circumstances. After activating the system, he finds renewed hope and determination.
  • Sun Chengren, the vice president and sales director, is a loyal employee who has been with the company for over twenty years. He is dedicated, responsible, and cares deeply for Wei Kang and the company's well-being.

Significant Themes

  • Overcoming adversity: Wei Kang faces multiple challenges, including the company's bankruptcy and his own terminal illness, but he remains determined to find a way out of his predicament.
  • The power of hope: Despite his grim situation, Wei Kang finds hope in the activation of the pharmaceutical system, which offers him a chance to save his company and potentially his own life.
  • Loyalty and responsibility: Sun Chengren demonstrates loyalty to Wei Kang and the company, going above and beyond to help keep the business afloat.

Character Interactions

  • Wei Kang and Sun Chengren have a mentor-mentee relationship, with Sun Chengren acting as a guide and support for Wei Kang as he navigates the challenges of running the company.
  • Wei Kang's parents are mentioned but not present in the chapter, serving as a driving force behind Wei Kang's determination to save the company and preserve their legacy.
  • Wei Kang's interactions with the pharmaceutical system are minimal in this chapter, but they set the stage for future developments and potential assistance from the system.

Ch. 2First Extraction: Testing the Drug on Himself

Key Plot Points and Events

  • Wei Kang discovers a Newbie Gift Pack in the system, granting him a free use of the Drug Side Effect Extraction Function.
  • He decides to test the drug on himself, choosing a formula for Chronic Bronchitis with a minute cancer cell inhibiting side effect.
  • Wei Kang produces enough tablets for a seven-day treatment and ingests the first pill.

Character Developments

  • Wei Kang shows determination and desperation in his quest to treat his late-stage liver cancer, willing to test the drug on himself.
  • He demonstrates his pharmaceutical knowledge and understanding of drug development processes.

Significant Themes

  • The dual nature of drug side effects, which can sometimes be beneficial or even transformative.
  • The importance of perseverance and risk-taking in scientific research and drug development.

Character Interactions

  • Wei Kang interacts with the system, using its functions to extract a desired side effect and create a new drug.
  • Although not physically present, Wei Kang's parents are remembered through the laboratory they built to support his dreams.

Ch. 3Trial Drug Succeeds, Anti-Cancer Drug Debuts

Key Plot Points and Events

  • Wei Kang, diagnosed with late-stage liver cancer, returns to the hospital after three days, requesting a follow-up examination.
  • Dr. Li Xuemin, initially skeptical, re-examines Wei Kang's test results and is astonished by the significant improvement.
  • Wei Kang reveals he has been secretly testing a new anti-cancer drug developed by his company, Sanqing Pharmaceutical.
  • News of the drug's effectiveness spreads rapidly among patients, leading to a surge of interest and willingness to participate in future clinical trials.

Character Developments

  • Wei Kang: Confirms his company's new drug is highly effective, showing courage and determination in testing it on himself. He also demonstrates leadership and responsibility in considering the drug's potential impact on others.
  • Dr. Li Xuemin: Initially skeptical, he becomes excited and committed to studying Wei Kang's case after seeing the dramatic improvement in his test results.
  • Dr. Jian Lianyun: Shows professionalism and empathy in questioning Wei Kang and expressing her eagerness to study his condition further.

Significant Themes

  • Hope and Miracles: The new drug represents hope for cancer patients and a potential medical breakthrough.
  • Responsibility and Leadership: Wei Kang's decision to test the drug on himself and his consideration for others reflect his sense of responsibility and leadership.
  • Medical Advancements and Ethics: The discovery of the drug raises questions about its development, testing, and distribution.

Character Interactions

  • Wei Kang and Dr. Li Xuemin: Their interaction highlights the doctor's initial skepticism and eventual excitement about Wei Kang's condition.
  • Wei Kang and Dr. Jian Lianyun: Their conversation demonstrates mutual respect and a shared commitment to understanding and treating Wei Kang's condition.
  • Wei Kang and the Patients: The patients' reactions to the news of the drug's effectiveness show their desperation for hope and treatment, as well as their willingness to participate in clinical trials.

Ch. 4Rejecting the Acquisition, Reclaiming the Shares

Key Plot Points and Events

  • Wei Kang agrees to stay in touch with Dr. Jian and asks him to set up a Patient Support Group for the upcoming Phase III Clinical Trial.
  • Wei Kang refuses to be hospitalized, considering it impractical given the company's crisis.
  • Wei Kang overhears three minor shareholders discussing the company's acquisition by New Beauty and expressing their desire to withdraw their shares.
  • Wei Kang confronts the shareholders, refuses the acquisition, and offers his apartment to settle their shares.

Character Developments

  • Wei Kang demonstrates determination and strategic thinking in refusing the acquisition and dealing with the shareholders. He shows a newfound ruthlessness and willingness to stand up to the company's problems.
  • The minor shareholders (Old Liu, Old Wang, Old Chen) are revealed to be self-serving and only interested in their own profits, with little regard for the company's future.
  • Sun Chengren (Uncle Sun) initially tries to mediate but ultimately supports Wei Kang's decision.

Significant Themes

  • The struggle for control and power within the company.
  • The tension between short-term gains and long-term vision.
  • The importance of standing up to challenges and making tough decisions.

Character Interactions

  • Wei Kang vs. Minor Shareholders: Wei Kang asserts his authority as the major shareholder and refuses to be manipulated by the minor shareholders.
  • Wei Kang and Sun Chengren: Wei Kang seeks Sun Chengren's support in dealing with the shareholders, and Sun Chengren ultimately helps him draft a share transfer agreement.
  • Minor Shareholders among themselves: The shareholders bicker and argue, revealing their self-centered attitudes and lack of unity.

Ch. 5Working Together to Accelerate Clinical Trials

Key Plot Points and Events

  • Wei Kang successfully negotiates with former shareholders to buy back 20% of the company's shares at a low price.
  • Wei Kang reveals that a new improved anti-cancer drug has shown promising results and is ready for Phase II clinical trials.
  • Wei Kang and Old Sun discuss strategies to prioritize and accelerate the clinical trials, including delaying payments to suppliers, collecting overdue receivables, and reorganizing the company.

Character Developments

  • Wei Kang demonstrates his negotiation skills and business acumen, securing a favorable deal with the former shareholders.
  • Wei Kang shows consideration for Old Sun's health and well-being, not revealing the full extent of the drug's success to avoid worrying him.
  • Old Sun displays his loyalty and dedication to Wei Kang and the company, offering to help with various tasks to support the clinical trials.

Significant Themes

  • The importance of strategic partnerships and alliances in business, as seen in Wei Kang's relationship with Old Sun.
  • The high risks and rewards of new drug development in the pharmaceutical industry.
  • The challenges and potential solutions for securing funding and resources for clinical trials.

Character Interactions

  • Wei Kang and Old Sun: They exhibit a strong, trusting relationship, with Old Sun acting as a mentor and confidant to Wei Kang. They work together to overcome challenges and make decisions for the company's benefit.
  • Wei Kang and Zhang Bo: Wei Kang contacts Zhang Bo, the head of a CRO company, to discuss accelerating the clinical trials for the new drug. Their interaction highlights the importance of outsourcing services in the pharmaceutical industry and the potential for successful collaboration between companies.

Ch. 6Astonishing Data, Hospital Follow-Up

Key Plot Points and Events

  • Zhang Bo, excited by the Phase II trial results, reports to Wei Kang that their anti-cancer drug has shown remarkable effects with no side effects.
  • Wei Kang decides to proceed with Phase III Clinical Trial, aiming to get the drug to market within six months.
  • Wei Kang receives a call from Dr. Li Xuemin, reminding him of his follow-up appointment. He decides to visit Dr. Jian instead.
  • Wei Kang undergoes follow-up examinations with Dr. Jian, who is astonished by the drug's effects.
  • Wei Kang requests Dr. Jian's help in recruiting volunteers for the Phase III trial.

Character Developments

  • Wei Kang: Shows determination and decisiveness in pushing forward with the drug trial. He also demonstrates a pleasant mood when interacting with Dr. Jian.
  • Zhang Bo: Exhibits enthusiasm and support for the drug's development and market potential.
  • Dr. Jian Lianyun: Shows dedication to her work and is amazed by the drug's effects. She agrees to help recruit volunteers for the trial.
  • Dr. Li Xuemin: Briefly appears, showing concern for Wei Kang's follow-up examinations.

Significant Themes

  • The rapid development and promising results of the anti-cancer drug.
  • The importance of clinical trials and their stages (Phase II to Phase III).
  • The potential market success and support for the drug.
  • The professionalism and dedication of medical practitioners.

Character Interactions

  • Wei Kang and Zhang Bo: They discuss the drug's trial results, Phase III plans, and market potential.
  • Wei Kang and Dr. Jian Lianyun: They interact professionally, with Dr. Jian expressing amazement at the drug's effects and agreeing to help with the trial.
  • Wei Kang and Dr. Li Xuemin: They have a brief phone conversation about Wei Kang's follow-up appointment.

Ch. 7Father and Daughter Both Shocked, Live-Streaming the Drug Trial

Key Plot Points and Events

  • Jian Lianyun, a doctor, is astonished by the Phase II clinical data of a new anti-cancer drug, which shows remarkable efficacy and no side effects.
  • She shares the news with her father, a prominent oncologist, who is initially skeptical but agrees to consider the drug for a special patient after seeing the data.
  • Jian Lianyun posts in a WeChat group to recruit volunteers for the Phase III clinical trial of the drug.
  • Cao Jinmei, a young lymphoma patient and livestreamer, decides to participate in the trial and plans to livestream her experience.

Character Developments

  • Jian Lianyun: She becomes more enthusiastic about the new drug's potential and is determined to help make it accessible to cancer patients. She also shows frustration with her father's persistence in discussing her personal life.
  • Cao Jinmei: Despite her terminal illness, she remains optimistic and finds purpose in livestreaming her journey, inspiring her followers to appreciate life. She decides to participate in the drug trial, hoping for a miracle.

Significant Themes

  • Hope and resilience in the face of terminal illness.
  • The impact of new medical advancements on patients and society.
  • The power of community and support, as seen through Cao Jinmei's livestreaming platform.

Character Interactions

  • Jian Lianyun and her father: Their conversation highlights their shared passion for medicine but also reveals their differing views on the new drug and Jian Lianyun's personal life.
  • Cao Jinmei and her fans: Through her livestream, Cao Jinmei interacts with her followers, providing them with comfort, support, and inspiration despite her own dire circumstances.

Ch. 8First Day of the Drug Trial Livestream

Key Plot Points and Events

  • Cao Jinmei, a terminal cancer patient, cries during her livestream, surprising her fans.
  • She reveals that she saw an improved Grandma Liu, also a terminal cancer patient, who had started the drug trial a week before her.
  • Cao Jinmei announces she's in the second batch of the trial and believes she'll improve soon.
  • Fans are skeptical but supportive. Some discuss a high-priced anti-cancer injection developed by Xinmei Group.
  • The next day, Cao Jinmei's livestream shows visible improvements in her skin color, posture, and energy levels.

Character Developments

  • Cao Jinmei: Shows resilience and hope despite her condition. She's open about her experiences and believes in the drug trial's effectiveness.
  • Grandma Liu: Not a main character but serves as a symbol of hope for Cao Jinmei and the viewers.
  • Fans: Initially supportive but skeptical, they become more convinced after seeing Cao Jinmei's improvements.

Significant Themes

  • Hope and resilience in the face of adversity.
  • The power of belief and self-suggestion in treatment.
  • The impact of medical advancements and their accessibility.

Character Interactions

  • Cao Jinmei interacts with her fans, who are initially comforting and later skeptical but supportive.
  • Cao Jinmei's encounter with Grandma Liu gives her hope and strength.

Ch. 9Miracle Drug Shocks the World, Hospital Overrun

Key Plot Points and Events

  • Cao Jinmei's livestream shows her visibly improving health, convincing viewers of the drug's efficacy.
  • On the third day, she appears fully cured, sparking global attention and a rush to Kun City First People's Hospital.
  • The hospital is overrun with patients and media, seeking information about the "miracle drug."

Character Developments

  • Cao Jinmei: She regains her health and vitality, becoming an inspiration to cancer patients worldwide.
  • Li Xuemin: He remains unaware of the online frenzy until he sees the crowd at the hospital.
  • Director Qin: He is overwhelmed by the sudden attention and tries to manage the situation.

Significant Themes

  • Hope and healing: Cao Jinmei's transformation symbolizes hope for cancer patients worldwide.
  • Misinformation and rumors: The three-day cure rumor spreads rapidly, causing a frenzy.
  • The power of social media: Cao Jinmei's livestream gains global attention, highlighting the influence of online platforms.

Character Interactions

  • Cao Jinmei interacts with her fans through livestreams, sharing her journey and encouraging others.
  • Director Qin interacts with the media, trying to clarify the misinformation about the drug.
  • Li Xuemin and other hospital staff react to the sudden influx of patients and media at the hospital.

Ch. 10Three Purities Makes a Name, New Beauty Catches Strays

Key Plot Points and Events

  • Three Purities Pharmaceutical, a small, unlisted company, gains overnight fame for developing a new anti-cancer drug that takes effect in three days.
  • Xinmei Group, a major pharmaceutical company, launches Akilunsi Injection, China's first approved CAR-T cell therapy product, at a high price.
  • A press conference for Akilunsi is held, where the high price and lack of medical insurance coverage are questioned, and Three Purities Pharmaceutical's drug is mentioned.

Character Developments

  • Wu Shiji, Xinmei Group's chairman, is portrayed as authoritative, confident, and skilled in handling media questions, but also ruthless and money-minded.
  • Zhang Chunmei, a cancer patient, is grateful for her treatment and recovery using Akilunsi Injection.

Significant Themes

  • The high cost of new drugs and the struggle for accessibility, particularly for cancer treatments.
  • The tension between profit-driven pharmaceutical companies and the patients who need their products.
  • The impact of social media and public opinion on pharmaceutical companies' reputations.

Character Interactions

  • Wu Shiji interacts with the media, presenting Xinmei Group's product and handling questions about its high price.
  • Wu Shiji and his assistant discuss the threat posed by Three Purities Pharmaceutical's drug and the negative public reaction to Xinmei Group's high prices.

Ch. 11Second Extraction, Miracle Whitening Drug

Key Plot Points and Events

  • Three former shareholders of Sanqing Pharmaceutical discover they've been swindled into trading their shares for a worthless apartment.
  • They learn about Sanqing's new miracle anti-cancer drug, which has gone viral, causing them to realize the extent of Wei Kang's deception.
  • Wei Kang, unaware of the shareholders' discovery, decides to extract a side effect from a failed dermatitis cream formula to create a whitening drug.

Character Developments

  • The three former shareholders (Old Liu, Old Chen, and Old Wang) become enraged and determined to take revenge on Wei Kang after realizing they've been tricked.
  • Wei Kang, driven by his desire to accumulate points and create profitable products, decides to develop a whitening drug.

Significant Themes

  • Deception and revenge: The former shareholders feel betrayed and seek retribution against Wei Kang.
  • Ambition and profit: Wei Kang's drive to succeed and make money leads him to explore new product opportunities.

Character Interactions

  • The three former shareholders interact, expressing their anger and frustration at being deceived by Wei Kang.
  • Wei Kang, isolated in his laboratory, makes decisions based on his own goals and knowledge, unaware of the external reaction to his company's new drug.

Ch. 12Official Announcement, New Drug Launch Conference

Key Plot Points and Events

  • Sanqing Pharmaceutical's anti-cancer drug trial goes viral, attracting media attention and overwhelming patient applications.
  • Wei Kang, the CEO, handles social media duties to promote the company and its new drug.
  • He announces a press conference for the drug's launch and hints at a potential beauty product collaboration.
  • The media and pharmaceutical industry eagerly await the Phase III data release.

Character Developments

  • Jian Lianyun, the doctor overseeing the trial, shows dedication and concern for patients, working tirelessly despite the overwhelming response.
  • Wei Kang demonstrates responsibility and adaptability, managing social media and ensuring the drug's supply despite his young age and the company's small size.

Significant Themes

  • The struggle against cancer and the hope for a cure.
  • The tension between profit and patient care in the pharmaceutical industry.
  • The power of social media and public opinion in shaping a company's reputation.

Character Interactions

  • Jian Lianyun and Wei Kang collaborate to manage the drug trial and ensure its success, showing mutual respect and concern for each other's well-being.
  • Wei Kang interacts with the public via social media, fostering goodwill and anticipation for the drug's launch.
  • The media and pharmaceutical industry engage with Wei Kang and Sanqing Pharmaceutical, expressing interest and anticipation for the new drug.

Ch. 13President Wei's Sweet, Tempting Promise

Key Plot Points and Events

  • Wei Kang, the president of Three Purities Pharmaceutical Company, meets with various department heads to discuss the successful development of their New Anti-Cancer Drug and the urgent need for raw materials.
  • He promises Zhao Xiaojie, the purchasing manager, that the company will grow into a global pharmaceutical giant, and he will be one of its founding veterans.
  • Wei Kang motivates the R&D team, led by Li Zhong, by promoting Li Zhong to team leader and promising them generous bonuses and future promotions.
  • Wei Kang meets with other department heads, reassuring them about the company's upcoming success and encouraging them to work harder.
  • Wei Kang discovers the effectiveness of his newly developed Whitening Cream and decides to collaborate with cosmetics companies, adjusting the formula for a Phase II clinical trial with Zhang Bo, the general manager.

Character Developments

  • Wei Kang: Shows himself as a charismatic and ambitious leader who motivates his employees with promises of future growth and success. He is also a skilled scientist, having developed a New Anti-Cancer Drug and a Whitening Cream.
  • Zhao Xiaojie: The honest and diligent purchasing manager who is inspired by Wei Kang's vision for the company's future.
  • Li Zhong: The dedicated R&D team leader who is promoted by Wei Kang and feels grateful and motivated by the recognition of his hard work.

Significant Themes

  • Ambition and Vision: Wei Kang's grand vision for Three Purities Pharmaceutical Company inspires his employees and drives the company's success.
  • Hard Work and Recognition: Li Zhong's dedication and hard work are recognized and rewarded by Wei Kang, motivating him and his colleagues to work even harder.
  • Innovation and Collaboration: Wei Kang's development of the Whitening Cream and his plans to collaborate with cosmetics companies highlight the importance of innovation and partnerships in business success.

Character Interactions

  • Wei Kang and Zhao Xiaojie: Wei Kang motivates Zhao Xiaojie by painting a grand future for the company, inspiring him to work harder.
  • Wei Kang and the R&D team: Wei Kang encourages the R&D team, led by Li Zhong, by acknowledging their hard work and promising them future rewards and promotions.
  • Wei Kang and Zhang Bo: Wei Kang collaborates with Zhang Bo to conduct a Phase II clinical trial for the Whitening Cream, demonstrating their professional relationship and shared goals.

Ch. 14Sheng Changya's Surprise

Key Plot Points and Events

  • Sheng Changya, a junior product manager at Oulaiya Group, discovers a trending topic about Sanqing Pharmaceutical's New Anti-Cancer Drug on Langbo.
  • She contacts Wei Kang, the president of Sanqing Pharmaceutical, expressing interest in their Whitening and Spot-Removing Drug.
  • Wei Kang sends Sheng Changya a photo showing the dramatic whitening effect of the drug on a man's hand.
  • Wei Kang sends Sheng Changya a sample of the drug to try.
  • Sheng Changya applies the drug to her dark spots before bed.

Character Developments

  • Sheng Changya demonstrates her professionalism and sharp instinct in spotting potential products for her company.
  • Wei Kang shows eagerness to cooperate and provides a sample of the drug to prove its efficacy.

Significant Themes

  • The power of first impressions and initial appearances (the striking contrast between the two hands in the photo).
  • The impact of new technologies or products on the market (the potential of the Whitening and Spot-Removing Drug).

Character Interactions

  • Sheng Changya and Wei Kang communicate via email and WeChat, initially cautious but growing more cooperative as they discuss the potential of the drug.
  • Sheng Changya's interactions with colleagues are brief and distracted, showing her focus on the potential deal with Sanqing Pharmaceutical.

Ch. 15The Phase III Clinical Report Was Finally Out

Key Plot Points and Events

  • The Phase III clinical report for Sanqing Pharmaceutical's Whitening Drug is released.
  • Sheng Changya, a product manager at Oulaiya, is impressed by the drug's effectiveness and reaches out to Wei Kang, the president of Sanqing.
  • Wei Kang responds ambiguously, hinting that the highest bidder will get the drug's formula.
  • Sheng Changya understands the challenge of securing a good offer due to Oulaiya's corporate structure and her own position.
  • Wei Kang reviews the trial report, finding it stunning with no toxic reactions or skin irritations, and excellent tolerability.
  • He also receives the initial Phase III data for the anti-cancer drug, showing remarkable results in curing cancer in most patients within a month.
  • Wei Kang schedules a press conference for the new drug launch at the beginning of next month.

Character Developments

  • Sheng Changya becomes determined to secure the Whitening Drug formula or a joint development deal to boost her career.
  • Wei Kang demonstrates his business acumen and confidence in his products' effectiveness.

Significant Themes

  • The power dynamics and limitations within multinational corporations.
  • The importance of product safety and effectiveness in the cosmetics industry.
  • The potential impact of a revolutionary drug on the market and patients' lives.

Character Interactions

  • Sheng Changya and Wei Kang exchange messages about the Whitening Drug, with Wei Kang playing his cards close to his chest.
  • Wei Kang consults with Sun Chengren to plan the new drug launch conference.

Ch. 16International Giants Gather, General Manager Wu is Shocked

Key Plot Points and Events

  • Xinmei Pharmaceutical Group signs a patent licensing agreement with Pfizer Inc. for cardiovascular medicine.
  • General Manager Wu learns about Sanqing Pharmaceutical's upcoming press conference for their new broad-spectrum anti-cancer drug.
  • Wu and Andre attend Sanqing's press conference, where they meet other pharmaceutical giants, industry peers, and government officials.

Character Developments

  • General Manager Wu feels threatened by Sanqing's new drug and is determined to expose any flaws in it.
  • Andre, Pfizer's Asia-Pacific president, shows interest in Sanqing's anti-cancer drug, hinting at potential competition.

Significant Themes

  • Competition and rivalry within the pharmaceutical industry.
  • The potential impact of a new broad-spectrum anti-cancer drug on the market.
  • The attraction of the domestic market for international pharmaceutical giants.

Character Interactions

  • General Manager Wu and Andre discuss potential cooperation while also probing each other's interests in Sanqing's drug.
  • Wu and Andre meet other pharmaceutical executives, including Merck's Global President of Oncology and Roche Pharmaceuticals' representatives.
  • Wu feels jealous and threatened by the attention Sanqing's drug is receiving, contrasting with the reception for Xinmei's Anti-Cancer Injection.

Ch. 17Universal Doubt, Is This Data Really Not Faked?

Key Plot Points and Events

  • Sanqing Pharmaceutical's press conference for a new broad-spectrum anti-cancer drug begins.
  • Wei Kang presents clinical trial data, including a 100% cure rate and zero side effects across various cancer types, even brain metastases.
  • The audience reacts with disbelief and chaos, questioning the authenticity of the data.
  • Wei Kang distributes clinical trial reports to attendees and answers routine questions from reporters.
  • Dr. Schmitz, Merck's Global President of Oncology, challenges Wei Kang, questioning the authenticity of the data and accusing him of treating patients' lives as a joke or blaspheming science.

Character Developments

  • Wei Kang demonstrates confidence and poise in presenting the data but shows nervousness when the audience reacts with skepticism.
  • Dr. Schmitz is portrayed as a serious and experienced figure in the pharmaceutical industry, expressing disbelief and skepticism towards the presented data.

Significant Themes

  • Skepticism and disbelief in the face of extraordinary claims (i.e., a 100% cure rate with zero side effects).
  • The responsibility of pharmaceutical companies in presenting accurate and honest data regarding their products.
  • The tension between innovation and the established norms and expectations within the pharmaceutical industry.

Character Interactions

  • Wei Kang and Sun Chengren walk onto the stage together, indicating a level of collaboration or partnership.
  • Wei Kang interacts with the audience, attempting to maintain order and address their doubts and questions.
  • Dr. Schmitz directly challenges Wei Kang, questioning the authenticity of the data and the integrity of Sanqing Pharmaceutical's claims.

Ch. 18Responding to Doubts, Slapping Faces On The Spot

Key Plot Points and Events

  • Dr. Schmitz from Merck publicly questions the authenticity of Sanqing's New Anti-Cancer Drug clinical trial report at a press conference.
  • Wei Kang, Sanqing's president, defends the data and presents patient case files as evidence.
  • Domestic and international pharmaceutical companies react to the confrontation.

Character Developments

  • Wei Kang: Demonstrates sharp wit, confidence, and patriotism in defending Sanqing's drug and challenging Dr. Schmitz.
  • Dr. Schmitz: Shows arrogance and prejudice towards domestic pharmaceutical companies, but is left speechless by Wei Kang's responses.
  • General Manager Wu (Xinmei Pharmaceutical Group): Expresses pride in China's pharmaceutical industry and confirms Xinmei's advancements in targeted anti-cancer drugs.

Significant Themes

  • National Pride: Wei Kang and Wu defend the capabilities of China's pharmaceutical industry against foreign skepticism.
  • Integrity vs. Deception: The authenticity of Sanqing's clinical trial data is called into question, highlighting the importance of honesty and credibility in the pharmaceutical industry.
  • Global Competition: The confrontation between Sanqing and Merck reflects the intense competition among pharmaceutical companies worldwide.

Character Interactions

  • Wei Kang vs. Dr. Schmitz: A tense verbal exchange between Sanqing's president and Merck's representative, with Wei Kang gaining the upper hand.
  • Domestic vs. International Pharmaceutical Companies: Representatives from both sides react to the confrontation, with domestic companies expressing solidarity and international companies showing curiosity or gloating.
  • Wei Kang vs. General Manager Wu: Wei Kang acknowledges Wu's company's achievements, fostering a sense of unity among domestic pharmaceutical companies.

Ch. 19Pfizer Seeks Cooperation, Announces Whitening Drug

Key Plot Points and Events

  • Wei Kang presents real patient cases, demonstrating the New Anti-Cancer Drug's effectiveness.
  • Sanqing Pharmaceutical announces a new whitening and spot-removing drug.
  • Pfizer Inc.'s Asia-Pacific president, Dr. Andre, publicly acknowledges Sanqing's New Anti-Cancer Drug and proposes a partnership.
  • Representatives from other pharmaceutical companies also express interest in cooperating with Sanqing.

Character Developments

  • Wei Kang gains credibility and respect after presenting real patient cases.
  • Dr. Andre acknowledges Sanqing's drug, showing Pfizer's interest and validating Sanqing's work.
  • Pharmaceutical representatives shift from skepticism to eagerness to cooperate.

Significant Themes

  • The power of evidence and real-life examples in convincing skeptics.
  • The hierarchy of disdain within the pharmaceutical industry, with some drugs viewed as more prestigious than others.
  • The potential of beauty products and cosmetics in the market, despite their lower status in the pharmaceutical industry.

Character Interactions

  • Wei Kang interacts with the audience, presenting the drugs and handling questions.
  • Dr. Andre engages with Wei Kang, publicly acknowledging Sanqing's drug and proposing cooperation.
  • Pharmaceutical representatives interact with each other and with Wei Kang, expressing their interest in collaborating.

Ch. 20A Perfect Ending, Director Xie's Appreciation

Key Plot Points and Events

  • Sanqing Pharmaceutical's anti-cancer drug launch conference concludes successfully.
  • Wei Kang is satisfied with the outcome and plans to target the international market.
  • Director Xie from the city Drug Administration Bureau praises Wei Kang and Sanqing Pharmaceutical, promising support for future clinical trials.
  • Wei Kang searches for Dr. Jian but cannot find her, feeling disappointed.
  • Sun Chengren expresses relief and pride in Wei Kang's leadership.
  • At the dinner, Wei Kang toasts everyone, and representatives from other companies offer toasts as well. Andre from Pfizer struggles with the drinking culture.

Character Developments

  • Wei Kang: Shows satisfaction with the conference's success and plans for the international market. He feels grateful towards Dr. Jian and is disappointed at not finding her. He remains composed and confident in his leadership.
  • Director Xie: Praises Wei Kang and Sanqing Pharmaceutical, offering support and encouragement. He advises Wei Kang to be assertive when dealing with foreign companies.
  • Sun Chengren: Expresses relief and pride in Wei Kang's leadership, feeling that Sanqing Pharmaceutical's future is bright under his guidance.
  • Andre (Pfizer): Struggles with the intense drinking culture at the dinner, eventually replacing his Maotai with Sprite.

Significant Themes

  • Success and ambition: Wei Kang's satisfaction with the conference's success and his plans for the international market highlight his ambition and drive.
  • Gratitude and recognition: Wei Kang feels grateful towards Dr. Jian, and Director Xie praises Wei Kang and Sanqing Pharmaceutical, emphasizing the importance of recognition and appreciation.
  • Cultural differences: Andre's struggle with the drinking culture at the dinner highlights the cultural differences between Eastern and Western business practices.

Character Interactions

  • Wei Kang and Director Xie: They exchange compliments and promises of support, demonstrating a positive professional relationship.
  • Wei Kang and Sun Chengren: They express relief and pride in each other's efforts, strengthening their bond as mentor and protégé.
  • Representatives at the dinner: They offer toasts to each other, fostering a sense of camaraderie and networking among the attendees.
Show
Page 1 of 34